SenseGuard A breakthrough respiratory monitoring device incorporating novel na...
SenseGuard A breakthrough respiratory monitoring device incorporating novel nanotechnology based sensors
Respiratory rate is a vital sign used to monitor the progression of illness both in hospitals and at home, particularly when dealing with at-risk patients. The continuous monitoring is key for patients with respiratory conditions...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SenseGuard
A breakthrough respiratory monitoring device incorporating n...
4M€
Cerrado
WELMO
Wearable Electronics for Effective Lung Monitoring
4M€
Cerrado
PDC2022-133039-I00
ISPOSITIVO NANOANALITICO DEL ALIENTO PARA DETECTAR LAS PRIME...
144K€
Cerrado
PTQ-10-03209
Desarrollo de multi-biosensores para analitos en sudor y su...
64K€
Cerrado
TED2021-131209B-I00
SISTEMA DE TELEASISTENCIA BASADO EN TEJIDOS INTELIGENTES PAR...
115K€
Cerrado
WELCOME
WELCOME Wearable Sensing and Smart Cloud Computing for Int...
8M€
Cerrado
Información proyecto SenseGuard
Duración del proyecto: 5 meses
Fecha Inicio: 2019-04-26
Fecha Fin: 2019-09-30
Líder del proyecto
NanoVationGS
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Respiratory rate is a vital sign used to monitor the progression of illness both in hospitals and at home, particularly when dealing with at-risk patients. The continuous monitoring is key for patients with respiratory conditions (i.e. asthma), Chronic Obstructive Pulmonary Diseases (COPD) or pneumonia, with cardiovascular conditions, as well as elderly with comorbidities and prematurely born babies or babies with respiratory conditions.
SenseGuard respiratory monitoring device - is a decision support tool that assists practitioners in better monitoring patients with respiratory conditions like and at risks of deterioration. SenseGuard enables effective generation of alerts to clinical personnel, at the earliest moment following a change in patient’s status, at the hospital or at home. Due to its direct and high-resolution respiratory sensors, SenseGuard is able to continuously monitor pulmonary function on a breath-to-breath basis, unmatched by other technologies. SenseGuardTM can effectively monitor all at-risk patients.
NanoVation is an Israeli SME, founded in 2014, which develops and integrates nanomaterial-based sensors for medical applications and general purposes. Run by an experienced and multi-disciplinary team, NanoVation was granted several EU and non-EU projects, one of which awarded the 2018 Innovation Award by the European Commission. So far, NanoVation has raised and invested more than € 2.5M into the development of SenseGuard. To have it fully projected at a European and global level, NanoVation needs a further investment of €2.2M to complete product development and set up a solid EU value chain.
The proposed work in Phase 1 of the SME instrument fits into the company overall plan to reach the market by contributing the financial resources needed to plan a fast sound wider deployment of SenseGuard and its market uptake.